-

PathogenX Launches PX2 Technology for Fast, Compliant Disposal of In-Facility Medical Waste

CARMEL, Calif.--(BUSINESS WIRE)--Carmel-based PathogenX, a medical device company which develops, manufactures, and distributes proprietary technology designed to dramatically simplify the process of medical waste disposal, today announced the official launch of its unique, double-batch, on-site sterilization device, the PX2.

PathogenX designed the PX2 – a stand-alone device that can easily be placed on a countertop – to safely and efficiently render regulated medical waste (such as sharps) completely sterile, unrecognizable and non-reusable in compliance with all federal EPA, CDC and OSHA standards and guidelines. Each PX2 device is capable of processing up to 10 gallons of medical waste per day.

The PX2 system destroys all microbes (including COVID-19) while melting the biomedical waste so that a resulting “brick” of harmless, sterilized material can be easily disposed of in the standard trash.

Disposing of medical waste on-site with the PX2 is also considerably less expensive than haul-and-treat services and the company offers its customers financing and lease-to-own options so that the device pays for itself.

“We are excited to be launching PX2, a genuine game-changer for doctors, dentists, veterinarians, sports teams, home health care workers, nursing homes, and any other organizations that have been dealing with the expensive and dangerous nuisance of generating modest amounts of medical waste,” said PathogenX CEO Chuck Berkeley. “PX2 was created in response to distinct needs our team of industry pros have observed across decades working with health professionals. With PX2 we check a number of boxes – efficiency, cost-savings, environmental responsibility, safety and compliance. Plus, in today’s unpredictable and challenging climate, we are bringing something to healthcare workers on the front lines that removes the issue of having to manage contaminated sharps.”

PathogenX’s PX2 technology is being produced now to meet demand at select treatment locations and will be ramping up for full national distribution later this summer.

The mission of PathogenX, Inc. is to reimagine and change the way nearly one million U.S. low-volume generators manage their infectious waste by offering an economic, efficient and environmentally safe solution, which also serves to eliminate liability. Learn more at pathogenx.com.

Note to media: photos of PX2 device and images of post-PX2’d medical waste – rendered harmless and fully sterilized, are available upon request.

Contacts

Paul Williams, 310-569-0023, paul@medialinecommunications.com

PathogenX


Release Summary
PathogenX has launched its PX2 technology, which enables healthcare professionals to safely and easily dispose of sharps and medical waste.
Release Versions

Contacts

Paul Williams, 310-569-0023, paul@medialinecommunications.com

More News From PathogenX

PathogenX Adds Jamie Moriarty to Board of Directors and Names Robert Gurecka National Sales Director

CARMEL, Calif.--(BUSINESS WIRE)--PathogenX has added Jamie Moriarty to its board of directors and has named Robert Gurecka its new national sales director....

PathogenX Now Approved to Sell PX2 Technology to the Canadian Nationwide Market

CARMEL, Calif.--(BUSINESS WIRE)--PathogenX is approved to sell its PX2 in-office, medical waste disposal technology to the Canadian nationwide market....

PathogenX Names Chuck Berkeley Chairman of the Board

CARMEL, Calif.--(BUSINESS WIRE)--Carmel-based medical device company PathogenX has named Chuck Berkeley Chairman of its Board of Directors. Berkeley, a founder of PathogenX, will continue to also serve in his current role as CEO of the company. Berkeley has spent the last 10 of his 20-year sales and management career in the medical device and healthcare technology sector. Prior to his current role as co-founder and CEO for Cypress Holdings Group, Inc, the parent company of PathogenX, Berkeley f...
Back to Newsroom